The beneficial effects of combining pharmacological and psychosocial treatment on remission and functional outcome in outpatients with schizophrenia

被引:21
|
作者
Valencia, M. [1 ]
Fresan, A. [2 ]
Juarez, F. [1 ]
Escamilla, R. [3 ]
Saracco, R. [3 ]
机构
[1] Natl Inst Psychiat Ramon de la Fuente, Div Epidemiol & Psychosocial Res, Mexico City, DF, Mexico
[2] Natl Inst Psychiat Ramon de la Fuente, Div Sci Res, Mexico City, DF, Mexico
[3] Natl Inst Psychiat Ramon de la Fuente, Schizophrenia Clin, Mexico City, DF, Mexico
关键词
Schizophrenia; Pharmacotherapy; Psychosocial treatment; Remission; Functional outcome; NEGATIVE SYNDROME SCALE; FOLLOW-UP; PSYCHOLOGICAL THERAPY; SYMPTOMATIC REMISSION; RECOVERY; SKILLS; METAANALYSIS; CRITERIA;
D O I
10.1016/j.jpsychires.2013.09.006
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The effects of pharmacological and psychosocial treatment on remission and the functional outcome in outpatients with schizophrenia were evaluated. Remission was assessed according to the criteria proposed by the Remission in Schizophrenia Working group and psychosocial functioning according to the Global Assessment of Functioning with a score > 60. Functional outcome was the result of these two variables. Method: One hundred fifty two patients were randomized to receive either, antipsychotic treatment as usual (TAU) or social skills training and family psychoeducation in addition to TAU. A final sample of 119 patients: n = 68 in the social skills training group, and n = 51 in the TAU group completed the study protocol. Patients were assessed at baseline and at 6-month follow-up. Results: At the end of the study, 80% of the patients fulfilled the criteria for symptomatic remission: 62 patients (91.2%) in the social skills training group in contrast to 34 patients (66.7%) in the TAU group. Functional improvement criteria were accomplished by 41 patients (34.5%) at the endpoint of the study. Forty of these patients (58.8%) belonged to social skills training and one patient to customary treatment (chi(2) = 41.7, df 1, p < 0.001) and when criteria for symptomatic remission and functional improvement were combined, 39 patients (97.5%) of the social skills training group and one patient (1.9%) of the customary treatment group achieved functional outcome. Conclusion: The results emphasize the need for psychosocial interventions as conjoint to pharmacological treatment to improve functional outcome in schizophrenia patients. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1886 / 1892
页数:7
相关论文
共 50 条
  • [41] Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment
    Laengle, G.
    Steinert, T.
    Weiser, P.
    Schepp, W.
    Jaeger, S.
    Pfiffner, C.
    Frasch, K.
    Eschweiler, G. W.
    Messer, T.
    Croissant, D.
    Becker, T.
    Kilian, R.
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2012, 125 (05) : 372 - 381
  • [42] Coping, treatment motivation and psychosocial functioning in schizophrenia: testing mediator and moderator effects
    Semenova, N.
    Komissarov, A.
    [J]. EUROPEAN PSYCHIATRY, 2019, 56 : S282 - S282
  • [43] INPATIENT PSYCHOSOCIAL TREATMENT OF CHRONIC-SCHIZOPHRENIA - NEGATIVE EFFECTS AND CURRENT GUIDELINES
    DRAKE, RE
    SEDERER, LI
    [J]. HOSPITAL AND COMMUNITY PSYCHIATRY, 1986, 37 (09): : 897 - 901
  • [44] Remission of psychotic symptoms and long-term functional outcomes in the treatment schizophrenia in usual care
    Ascher-Svanum, H
    Zhu, B
    Faries, DE
    Jiang, Q
    Rosenheck, RA
    Brown, J
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S389 - S389
  • [45] Remission of psychotic symptoms and long-term functional outcomes in the treatment of schizophrenia in usual care
    Ascher-Svanum, H
    Zhu, B
    Faries, D
    Jiang, Q
    Rosenheck, RA
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 277 - 277
  • [46] Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder
    Lee, Dustin C.
    Schlienz, Nicolas J.
    Peters, Erica N.
    Dworkin, Robert H.
    Turk, Dennis C.
    Strain, Eric C.
    Vandrey, Ryan
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2019, 194 : 500 - 517
  • [47] Depot haloperidol treatment in outpatients with schizophrenia on monotherapy:: Impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome
    Panagiotidis, Georgios
    Arthur, Holger W.
    Lindh, Jonatan D.
    Dahl, Marja-Liisa
    Sjoqvist, Folke
    [J]. THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 417 - 422
  • [48] Clinical and functional outcome of treatment-refractory first-episode schizophrenia
    Phahladira, L.
    Emsley, R.
    Asmal, L.
    Chiliza, B.
    [J]. SOUTH AFRICAN JOURNAL OF PSYCHIATRY, 2014, 20 (03) : 107 - 107
  • [49] Clozapine improves long term functional outcome in treatment resistant patients with schizophrenia
    Tek, C
    Gold, JM
    Buchanan, RW
    [J]. SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 247 - 247
  • [50] Early improvement as a predictor of treatment response and remission in patients with acute schizophrenia: effects of asenapine
    Leucht, S.
    Zhao, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S470 - S470